Premium Information is available for this item - Upgrade for $1 a day
6505-00-074-2976
Usp Iothalamate Sodium Injection
6505000742976 000742976 NDC00019-0926-15
November 2023
6

Marketplace 6505-00-074-2976
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-074-2976 5+ Documents (More...)
/fsg-65/fsc-6505/us 6505-00-074-2976 Usp Iothalamate Sodium Injection 000742976 RQST NE Updated Every
Day 6505-00-074-2976 RQST Updated Every /fsg-65/fsc-6505/us 6505-00-074-2976 Usp Iothalamate Sodium
/fsg-65/fsc-6505/us 6505-00-074-2976 Usp Iothalamate Sodium Injection 000742976 Sodium Injection 000742976
Sodium Injection 007844977 /fsg-65/fsc-6505/us 6505-00-958-6513 Usp Iothalamate Sodium Injection 000742976
-00-074-2976 Usp Iothalamate Sodium Injection 000742976 Usp Iothalamate Sodium Injection 009586513 Sodium
Injection 000742976 6505-01-130-4675 6505-00- 074-2976 6505-00-958-6513 https Related to 6505-00-784
fsg-65/fsc-6505/us 6505-01-097-0668 Container Quantity [CSCW]50 NATO Stock Numbers Related to 6505-00-074-2976
0668 Usp Iothalamate Sodium Injection 010970668 Iothalamate Sodium Injection 011304675 Injection 000742976
Usp Iothalamate Sodium Injection 000742976 6505/us 6505-00-958-6513 Usp Iothalamate Sodium Injection
009586513 Sodium Injection 000742976 6505-01-130-4675 Usp Iothalamate Sodium Injection 000742976 Usp
Restrictions 6505-00-074-2976
6505-00-074-2976 is a Usp Iothalamate Sodium Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-074-2976
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-074-2976
- Part Number
- Manufacturer
- Status
- NDC00019-0926-15
- Manufacturer
- 37940 - Mallinckrodt Inc (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-00-074-2976
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 80.000 Percentage, W/V Iothalamate Sodium Active Ingredient
- Administration [CSGS]
- Intra-Arterial Or Intravenous
- Primary Container Content Quantity [CRLK]
- 50.000 Milliliters
- Primary Container Type [CQCT]
- Vial
- Pharmaceutical Vehicle Type [AKJQ]
- Aqueous
- Total Primary Container Quantity [CSCW]
- 50
NATO Stock Numbers Related to 6505-00-074-2976
Freight Information 6505-00-074-2976
6505-00-074-2976 has freight characteristics.. 6505-00-074-2976 has a variance between NMFC and UFC when transported by rail and the description should be consulted.